FMS — FRESENIUS MED CARE AKTIENGESELLSCHAFT SPONSORED ADR REPSTG SHS ISIN#US3580291066

Ownership history in SEARLE & CO.  ·  42 quarters on record

This page tracks every 13F SEC filing in which SEARLE & CO. reported a position in FRESENIUS MED CARE AKTIENGESELLSCHAFT SPONSORED ADR REPSTG SHS ISIN#US3580291066 (FMS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.5% (2016 Q4)
Avg. % of fund
0.49%
First filed
2015 Q2
Last filed
2025 Q4
Quarters held
42
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 80,725 — 0% 0.50% $1.9M $23.82
2025 Q3 ADDED 80,725 +57,437 +246.6% 0.56% $2.1M $26.33
2025 Q2 UNCHANGED 23,288 — 0% 0.19% $665K $28.57
2025 Q1 UNCHANGED 23,288 — 0% 0.17% $580K $24.21
38 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    FMS price (monthly, adj. close)

Other funds also holding FMS

As of 2025 Q4 — sorted by position size

FIDUCIARY MANAGEMENT INC /WI/ 3Y 7Y 1.3% NIA IMPACT ADVISORS, LLC 3Y 1.22% PZENA INVESTMENT MANAGEMENT LLC 3Y 7Y 1.05% XY Capital Ltd 3Y 0.8% Integral Health Asset Management, LLC 3Y 0.77% TODD ASSET MANAGEMENT LLC 3Y 7Y 0.6% Corient IA LLC 0.34% DMC Group, LLC 3Y 0.31% HENNESSY ADVISORS INC 3Y 7Y 0.3% Uncommon Cents Investing LLC 3Y 7Y 0.23%
← Back to SEARLE & CO. Holdings